Brilique

Medicinal product

(Invented) name

Brilique

Active substance (s)

Tikagreloras

Strength

60 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B01AC24, Ticagrelor

Marketing authorisation holder

AstraZeneca AB, Švedija

Date of authorisation

2010-12-03

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Tikagreloras	60 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
65746	80255	1080255	lizdinė plokštelė	N14		Receptinis	EU/1/10/655/007	Netiekiama	-	-	No	-	-
65747	80256	1080256	lizdinė plokštelė	N56		Receptinis	EU/1/10/655/008	Netiekiama	-	-	No	-	-
65748	80257	1080257	lizdinė plokštelė	N60		Receptinis	EU/1/10/655/009	Netiekiama	-	-	No	-	-
65749	80258	1080258	lizdinė plokštelė	N168		Receptinis	EU/1/10/655/010	Netiekiama	-	-	No	-	-
65750	80259	1080259	lizdinė plokštelė	N180		Receptinis	EU/1/10/655/011	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2010-12-03	Registruotas